Atyr Pharma Stock In The News
| LIFE Stock | USD 2.00 0.07 3.63% |
The tone or emotional content of news articles related to ATyr Pharma can affect its prices. Positive news sentiment can lead to an increase in demand for ATyr Pharma's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of ATyr Pharma's news coverage and content from conventional and social sources shows investors' bearish mood towards aTyr Pharma. The specific impact of ATyr Pharma news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of ATyr Pharma's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using ATyr Pharma headlines in addition to utilizing other, more conventional financial analysis modules. Check out ATyr Pharma Backtesting and ATyr Pharma Hype Analysis. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.
ATyr |
ATyr Pharma Today Top News and Investor Outlook
aTyr Pharma Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ATyr and other traded companies coverage. We help investors stay connected with ATyr headlines for the 18th of May 2024 to make an informed investment decision based on correlating the impacts of news items on ATyr Stock performance. Please note that trading solely based on the aTyr Pharma hype is not for everyone as timely availability and quick action are needed to avoid losses.ATyr Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ATyr earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about ATyr Pharma that are available to investors today. That information is available publicly through ATyr media outlets and privately through word of mouth or via ATyr internal channels. However, regardless of the origin, that massive amount of ATyr data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ATyr Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ATyr Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ATyr Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ATyr Pharma alpha.
ATyr Largest EPS Surprises
Earnings surprises can significantly impact ATyr Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-09 | 2023-09-30 | -0.23 | -0.2 | 0.03 | 13 | ||
2022-03-14 | 2021-12-31 | -0.28 | -0.31 | -0.03 | 10 | ||
2023-08-09 | 2023-06-30 | -0.28 | -0.22 | 0.06 | 21 | ||
2022-08-15 | 2022-06-30 | -0.38 | -0.44 | -0.06 | 15 | ||
2023-05-09 | 2023-03-31 | -0.4 | -0.29 | 0.11 | 27 | ||
2022-05-09 | 2022-03-31 | -0.33 | -0.44 | -0.11 | 33 |
ATyr Pharma Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to aTyr Pharma Stock. Current markets are slightly bullish. About 53% of major world exchanges and indexes are currently up. See today's market update for more information.
15th of May 2024
aTyr Pharma to Present Poster Describing Efzofitimods Mechanism of Action at the American ... at finance.yahoo.com
14th of May 2024
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT Stud... at globenewswire.com
6th of May 2024
aTyr Pharma to Present at Upcoming Investor Conferences at finance.yahoo.com
26th of April 2024
With 37 percent stake, aTyr Pharma, Inc. seems to have captured institutional investors in... at news.google.com
18th of April 2024
Bullish aTyr Pharma Insider Buying Worth US514.6k Yet To Pay Off at simplywall.st
4th of April 2024
aTyr Pharma Shows Strength Stock Moves Up 10.6 percent - Yahoo New Zealand News at news.google.com
26th of March 2024
3 Penny Stocks That Could Be Multibaggers in the Making March Edition at investorplace.com
18th of March 2024
aTyr Pharma Given Buy Rating at HC Wainwright - MarketBeat at news.google.com
15th of March 2024
aTyr Pharma, Inc. Q4 2023 Earnings Call Transcript at insidermonkey.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ATyr Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ATyr Pharma's short interest history, or implied volatility extrapolated from ATyr Pharma options trading.
Check out ATyr Pharma Backtesting and ATyr Pharma Hype Analysis. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 0.007 | Quarterly Revenue Growth (1.00) | Return On Assets (0.32) | Return On Equity (0.62) |
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.